The Efficacy and Tolerability of a Triple Therapy Containing a Potassium-Competitive Acid Blocker Compared With a 7-Day PPI-Based Low-Dose Clarithromycin Triple Therapy-Reference-Cited by-同舟云学术

The Efficacy and Tolerability of a Triple Therapy Containing a Potassium-Competitive Acid Blocker Compared With a 7-Day PPI-Based Low-Dose Clarithromycin Triple Therapy

Published:2016-07 Issue:7 Volume:111 Page:949-956
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:

Author:

Suzuki Sho,Gotoda Takuji,Kusano Chika,Iwatsuka Kunio,Moriyama Mitsuhiko

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Link

http://www.nature.com/articles/ajg2016182.pdf

Reference39 articles.

1. Current concepts in the management of Helicobacter pylori infectionthe Maastricht 2-2000 Consensus Report.;Malfertheiner;Aliment Pharmacol Ther,2002

2. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer?;Fuccio;Ann Intern Med,2009

3. Practice Parameters Committee of the American College of G. American College of Gastroenterology guideline on the management of Helicobacter pylori infection.;Chey;Am J Gastroenterol,2007

4. Prevalence of primary and secondary antimicrobial resistance of Helicobacter pylori in Korea from 2003 through 2012.;Lee;Helicobacter,2013

5. Long lasting inhibitors of the gastric H,K-ATPase.;Shin;Expert Rev Clin Pharmacol,2009

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Concomitant Use of Polaprezinc and Vonoprazan-Based Triple Therapy for Helicobacter pylori Eradication;Gastroenterology Insights;2024-05-11

2. Optimizing prediction models for pancreatic fistula after pancreatectomy: Current status and future perspectives;World Journal of Gastroenterology;2024-03-14

3. Vonoprazan-amoxicillin dual regimen with Saccharomyces boulardii as a rescue therapy for Helicobacter pylori: Current perspectives and implications;World Journal of Gastroenterology;2024-03-14

4. A Mini-review on Helicobacter pylori with Gastric Cancer and Available Treatments;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-03

5. Meta‐analysis of Helicobacter pylori eradication therapy using vonoprazan as an acid suppressor compared with bismuth quadruple therapy;Helicobacter;2024-03